Drugs · acquisition-cost intelligence
Klaron
Sodium sulfacetamide· ingredient sulfacetamideSulfonamides· SULFACETAMIDE SODIUM 100 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.53594
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sulfacetamide products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Sodium Sulfacetamide 8% and Sulfur 4% | $0.06467 | −$0.47130 |
| Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser | $0.07818 | −$0.45780 |
| OVACE | $0.11417 | −$0.42180 |
| Plexion | $0.12999 | −$0.40590 |
| AVAR | $0.17118 | −$0.36480 |
| Sodium Sulfacetamide 9% and Sulfur 4% Cleanser | $0.36031 | −$0.17560 |
| Avar-e | $0.68695 | +$0.15100 |
| sulfacetamide sodium | $1.86 | +$1.33 |
Medicare Part D coverage · CY2026
On 252 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 37% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.